NeuroID, a part of Experian logo — Next-Gen Behavior & Device: Detect Fraud Anywhere User Inter...

NeuroID, a part of Experian

Next-Gen Behavior & Device: Detect Fraud Anywhere User Interaction Occurs

Founded 2014 United States Whitefish, United States 42 employees Series B Total: $42.00M Analytics, Big Data +1

General Information

Company Name NeuroID, a part of Experian
Founded Year 2014
Location United States Whitefish, United States
Employees 42
Industries Analytics, Big Data, Insurtech
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with NeuroID, a part of Experian. To contact NeuroID, a part of Experian, visit neuro-id.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does NeuroID, a part of Experian compare?

A PDF of NeuroID, a part of Experian and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting NeuroID, a part of Experian soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About NeuroID, a part of Experian

NeuroID is a cutting-edge startup aiming to revolutionize fraud detection with its slogan "Next-Gen Behavior & Device: Detect Fraud Anywhere User Interaction Occurs". Their innovative approach combines the power of industry-leading behavioral analytics with advanced device and network intelligence to create the first line of defense against malicious bots, bad actors, and fraud rings. Positioning itself as a comprehensive solution, NeuroID secures the entire user lifecycle with a single integration, effectively preventing various fraudulent activities, from ID theft to ATO fraud, from the very first interaction. Operating from the United States, NeuroID demonstrates potential in the evolving cybersecurity and fintech landscape, offering a compelling solution to address the escalating threat of online fraud. As of now, information about NeuroID's founding date, specific industries targeted, and recent investment details is not publicly available. However, the company's innovative approach and potential to address critical industry challenges make it an intriguing prospect for venture capital investment and could position it as an attractive opportunity within the cybersecurity and fintech sectors.

Business keywords: fraud detection, behavioral analytics, device intelligence, network intelligence, user lifecycle, ID theft, ATO fraud, malicious bots, bad actors, fraud prevention, neuroID, tech innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Neuro $35.00M 3
Fin Capital, Canapi Ventures +1
04 Nov 2021
Series A Neuro $7.00M 3
Fin Capital, Canapi Ventures +1
08 Dec 2020

NeuroID, a part of Experian Alternatives & Competitors

View All Alternatives
NeuroID, a part of Experian vs
ThreatMark
ThreatMark United States

Bringing trust to the digital world by disrupting fraud.

Venture round
88 employees
AI, Analytics
NeuroID, a part of Experian vs
InAuth, Inc.
InAuth, Inc. United States

The digital intelligence experts for a mobile-first world.

Series A
4 employees
Analytics, Big Data
NeuroID, a part of Experian vs
BioCatch
BioCatch United States

We fight to make banking safer every day.

Private Equity
459 employees
Analytics, Big Data

FAQ About NeuroID, a part of Experian

Next-Gen Behavior & Device: Detect Fraud Anywhere User Interaction Occurs
NeuroID, a part of Experian was founded in 2014.
NeuroID, a part of Experian is headquartered in Whitefish, United States.
NeuroID, a part of Experian operates in Analytics, Big Data and Insurtech. Its work centres on fraud detection, behavioral analytics, device intelligence and network intelligence.
NeuroID, a part of Experian has approximately 42 employees.
NeuroID, a part of Experian has completed 2 funding rounds, raising a total of $42.00M. The latest funding stage is Series B.
Top alternatives and competitors to NeuroID, a part of Experian include ThreatMark, InAuth, Inc., BioCatch, NS8 Inc, TMT ID. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NeuroID, a part of Experian and ThreatMark are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for NeuroID, a part of Experian, https://bouncewatch.com/company/neuroid, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes